Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By JBP 2020 Trust Disclosed balance after: 50,000 Read SEC document |
| May 11, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,531.7241 F1 · balance_after: Includes 1,927.7241 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 08, 2020 Filed Oct 29, 2020 20:35 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,836.2235 F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 06, 2020 Filed May 8, 2020 19:48 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 2,700 | $101.52 | $274,095.90 |
DisclosureSEC source: 0001209191-20-028105 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,203 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.32 to $101.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2020 Filed May 8, 2020 19:48 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 6,309 | $100.80 | $635,940.89 |
DisclosureSEC source: 0001209191-20-028105 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,903 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.29 to $101.08, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2020 Filed May 8, 2020 19:48 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 15,211 | $99.71 | $1,516,617.32 |
DisclosureSEC source: 0001209191-20-028105 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,212 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.22 to $100.19, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:10 UTC |
Frist William RDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027350 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,036 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the 2021 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:06 UTC |
FRIST THOMAS F IIIDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027347 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,980 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the 2021 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:04 UTC |
Riley Wayne JosephDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027346 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,769 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:03 UTC |
MICHELSON MICHAEL WDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027345 · doc4.xml · nonDerivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,341 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:03 UTC |
HOLLIDAY CHARLES O JRDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027344 · doc4.xml · nonDerivative · entry 1 HOLLIDAY CHARLES O JR · CIK 0001127289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,172 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:03 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027343 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,700 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:02 UTC |
Dennis Robert JDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027342 · doc4.xml · nonDerivative · entry 1 Dennis Robert J · CIK 0001295441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,782 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:02 UTC |
CROFTON MEGDirector
|
GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027341 · doc4.xml · nonDerivative · entry 1 CROFTON MEG · CIK 0001665104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,275 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 59,375 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-027340 · doc4.xml · derivative · entry 8 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,375 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 2,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-027340 · doc4.xml · derivative · entry 7 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 37,655 | $104.86 | $3,948,503.30 |
DisclosureSEC source: 0001209191-20-027340 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,423 Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:01 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 61,875 | $37.18 | $2,300,512.50 |
DisclosureSEC source: 0001209191-20-027340 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed Oct 29, 2020 20:35 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 6,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,487 Read SEC document |
| May 01, 2020 Filed Oct 29, 2020 20:35 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 6,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,846.2235 F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 01, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 50,000 Read SEC document |
| May 01, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,531.7241 F1 · balance_after: Includes 1,927.7241 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Tax withholdingCommon Stock | 452 | $150.08 | $67,836.16 |
DisclosureSEC source: 0001209191-20-011780 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,232 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GrantCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011780 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,684 F1 · kind: On February 1, 2017, the reporting person was granted 1,460 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 1,548 | $150.08 | $232,323.84 |
DisclosureSEC source: 0001209191-20-011781 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,937 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantCommon Stock | 6,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011781 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,485 F1 · kind: On February 1, 2017, the reporting person was granted 5,290 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:14 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Tax withholdingCommon Stock | 3,310 | $150.08 | $496,764.80 |
DisclosureSEC source: 0001209191-20-011779 · doc4.xml · nonDerivative · entry 2 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,246 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:14 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
GrantCommon Stock | 10,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011779 · doc4.xml · nonDerivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,556 F1 · kind: On February 1, 2017, the reporting person was granted 9,250 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:14 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 1,548 | $150.08 | $232,323.84 |
DisclosureSEC source: 0001209191-20-011778 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,663 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:14 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantCommon Stock | 6,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011778 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,211 F1 · kind: On February 1, 2017, the reporting person was granted 5,290 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Tax withholdingCommon Stock | 3,066 | $150.08 | $460,145.28 |
DisclosureSEC source: 0001209191-20-011771 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011771 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,436 F1 · kind: On February 1, 2017, the reporting person was granted 6,610 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC |
RUTHERFORD BILL BCFO and EVP
|
Tax withholdingCommon Stock | 8,513 | $150.08 | $1,277,631.04 |
DisclosureSEC source: 0001209191-20-011769 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,145 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantCommon Stock | 24,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011769 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,658 F1 · kind: On February 1, 2017, the reporting person was granted 20,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:07 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Tax withholdingCommon Stock | 2,334 | $150.08 | $350,286.72 |
DisclosureSEC source: 0001209191-20-011767 · doc4.xml · nonDerivative · entry 3 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,562 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:07 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011767 · doc4.xml · nonDerivative · entry 2 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,896 F2 · kind: On November 1, 2017, the reporting person was granted 3,970 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:07 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantCommon Stock | 2,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011767 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,218 F1 · kind: On February 1, 2017, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:06 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Tax withholdingCommon Stock | 3,310 | $150.08 | $496,764.80 |
DisclosureSEC source: 0001209191-20-011766 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,307.1549 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:06 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
GrantCommon Stock | 10,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011766 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,617.1549 F1 · kind: On February 1, 2017, the reporting person was granted 9,250 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:05 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Tax withholdingCommon Stock | 1,796 | $150.08 | $269,543.68 |
DisclosureSEC source: 0001209191-20-011764 · doc4.xml · nonDerivative · entry 4 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,155.1196 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:05 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantCommon Stock | 7,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011764 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,951.1196 F1 · kind: On February 1, 2017, the reporting person was granted 5,960 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:06 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 5,167 | $150.00 | $775,050.00 |
DisclosureSEC source: 0001209191-20-011765 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:06 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 2,094 | $150.08 | $314,267.52 |
DisclosureSEC source: 0001209191-20-011765 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,863 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:06 UTC |
Paslick P. MartinSVP and CIO
|
GrantCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011765 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,957 F1 · kind: On February 1, 2017, the reporting person was granted 6,610 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:04 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 1,171 | $150.08 | $175,743.68 |
DisclosureSEC source: 0001209191-20-011762 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,627.8654 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:04 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011762 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,798.8654 F1 · kind: On February 1, 2017, the reporting person was granted 3,970 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:03 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 2,857 | $150.08 | $428,778.56 |
DisclosureSEC source: 0001209191-20-011761 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,902 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:03 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantCommon Stock | 9,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011761 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,759 F1 · kind: On February 1, 2017, the reporting person was granted 8,260 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:03 UTC | Tax withholdingCommon Stock | 13,088 | $150.08 | $1,964,247.04 |
DisclosureSEC source: 0001209191-20-011759 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,705 Read SEC document |
|
| February 19, 2020 Filed Feb 21, 2020 19:03 UTC | GrantCommon Stock | 35,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011759 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,793 F1 · kind: On February 1, 2017, the reporting person was granted 30,370 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.